Clarius Group LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.14M Buy
24,609
+5,073
+26% +$235K 0.07% 134
2025
Q1
$1.19M Buy
19,536
+3,995
+26% +$244K 0.07% 124
2024
Q4
$879K Buy
15,541
+1,409
+10% +$79.7K 0.06% 136
2024
Q3
$713K Sell
14,132
-2,103
-13% -$106K 0.05% 158
2024
Q2
$674K Buy
16,235
+8,061
+99% +$335K 0.05% 174
2024
Q1
$443K Sell
8,174
-4,691
-36% -$254K 0.03% 247
2023
Q4
$660K Sell
12,865
-3,293
-20% -$169K 0.05% 192
2023
Q3
$938K Sell
16,158
-6,301
-28% -$366K 0.09% 122
2023
Q2
$1.79M Buy
22,459
+917
+4% +$73.2K 0.14% 80
2023
Q1
$1.47M Sell
21,542
-968
-4% -$65.9K 0.12% 94
2022
Q4
$1.97M Buy
22,510
+2,159
+11% +$189K 0.18% 76
2022
Q3
$1.45M Buy
20,351
+451
+2% +$32.1K 0.14% 85
2022
Q2
$1.53M Buy
19,900
+811
+4% +$62.4K 0.15% 89
2022
Q1
$1.19M Hold
19,089
0.09% 116
2021
Q4
$1.19M Sell
19,089
-4,154
-18% -$259K 0.09% 116
2021
Q3
$1.38M Sell
23,243
-170
-0.7% -$10.1K 0.12% 93
2021
Q2
$1.56M Buy
23,413
+398
+2% +$26.6K 0.14% 88
2021
Q1
$1.45M Buy
23,015
+2,175
+10% +$137K 0.14% 89
2020
Q4
$1.29M Buy
20,840
+1,822
+10% +$113K 0.14% 82
2020
Q3
$1.15M Sell
19,018
-370
-2% -$22.3K 0.15% 75
2020
Q2
$1.14M Buy
19,388
+2,342
+14% +$138K 0.16% 72
2020
Q1
$950K Buy
17,046
+1,638
+11% +$91.3K 0.18% 66
2019
Q4
$1.03M Buy
15,408
+5,547
+56% +$369K 0.16% 73
2019
Q3
$500K Buy
9,861
+1,917
+24% +$97.2K 0.09% 118
2019
Q2
$360K Buy
7,944
+773
+11% +$35K 0.07% 142
2019
Q1
$342K Buy
7,171
+3,310
+86% +$158K 0.08% 126
2018
Q4
$201K Buy
3,861
+178
+5% +$9.27K 0.07% 117
2018
Q3
$229K Buy
+3,683
New +$229K 0.08% 111
2017
Q1
Sell
-4,413
Closed -$257K 92
2016
Q4
$257K Buy
4,413
+344
+8% +$20K 0.11% 76
2016
Q3
$217K Sell
4,069
-1,881
-32% -$100K 0.1% 85
2016
Q2
$438K Buy
5,950
+2,500
+72% +$184K 0.23% 52
2016
Q1
$220K Sell
3,450
-1,424
-29% -$90.8K 0.12% 77
2015
Q4
$335K Buy
+4,874
New +$335K 0.19% 52